Therapeutic Asset Ratings
120 results matching 1 filter
133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Volrustomig
Metastatic Colorectal Cancer
AstraZeneca
P2
CCC
(48)
Young Til
Metastatic Colorectal Cancer
National Cancer Institute (NCI)
P2
CCC
(48)
Modotuximab
Metastatic Colorectal Cancer
Institut de Recherches Internationales Servier
P3
CC
(47)
Spartalizumab
Metastatic Colorectal Cancer
SOLTI Breast Cancer Research Group
P2
CC
(46)
Eras-007
Metastatic Colorectal Cancer
Erasca, Inc.
P1/2
CC
(44)
Idelalisib
Metastatic Colorectal Cancer
Oslo University Hospital
P2
CC
(43)
Alnodesertib
Metastatic Colorectal Cancer
Artios Pharma Ltd
P1/2
CC
(41)
Arsenic Trioxide
Metastatic Colorectal Cancer
Nazarbayev University
P1/2
CC
(41)
AVOTACICLIB
Metastatic Colorectal Cancer
BeyondBio Inc.
P1/2
CC
(41)
bnt314
Metastatic Colorectal Cancer
BioNTech SE
P1/2
CC
(41)
bnt327
Metastatic Colorectal Cancer
BioNTech SE
P1/2
CC
(41)
D-isoascorbic acid
Metastatic Colorectal Cancer
Nazarbayev University
P1/2
CC
(41)
Docetaxel
Metastatic Colorectal Cancer
OncoC4, Inc.
P1/2
CC
(41)
Dupilumab
Metastatic Colorectal Cancer
Dan Feng
P1/2
CC
(41)
es104
Metastatic Colorectal Cancer
Elpiscience (Suzhou) Biopharma, Ltd.
P1/2
CC
(41)
Glumetinib
Metastatic Colorectal Cancer
Liu Huang
P1/2
CC
(41)
Gotistobart
Metastatic Colorectal Cancer
OncoC4, Inc.
P1/2
CC
(41)
IMMUNOGLOBULIN G4, ANTI-(HUMAN PROGRAMMED CELL DEATH PROTEIN 1) (HUMAN MONOCLONAL REGN2810 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL REGN2810 .KAPPA.-CHAIN, DIMER
Metastatic Colorectal Cancer
M.D. Anderson Cancer Center
P1/2
CC
(41)
Modufolin
Metastatic Colorectal Cancer
Isofol Medical AB
P1/2
CC
(41)
SUMAROTENE
Metastatic Colorectal Cancer
CuraCell TX AB
P1/2
CC
(41)
SX682
Metastatic Colorectal Cancer
National Cancer Institute (NCI)
P1/2
CC
(41)
Triadeno Vaccine
Metastatic Colorectal Cancer
National Cancer Institute (NCI)
P1/2
CC
(41)
Uromitexan
Metastatic Colorectal Cancer
CuraCell TX AB
P1/2
CC
(41)
Vilamakitug
Metastatic Colorectal Cancer
Centre Georges Francois Leclerc
P1/2
CC
(41)
DABIGATRAN ETEXILATE
Metastatic Colorectal Cancer
Hutchmed
P1
CC
(40)
Showing 76 to 100 of 120 assets
Previous
Page 4 of 5
Next